Provided by Tiger Trade Technology Pte. Ltd.

Immunic, Inc.

11.30
-0.5399-4.56%
Volume:193.19K
Turnover:2.22M
Market Cap:153.68M
PE:-2.83
High:11.95
Open:11.93
Low:11.25
Close:11.84
52wk High:17.43
52wk Low:5.06
Shares:13.60M
Float Shares:11.92M
Volume Ratio:0.59
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9979
EPS(LYR):-6.2414
ROE:-138.17%
ROA:-66.80%
PB:1.20
PE(LYR):-1.81

Loading ...

Immunic names Michael Panzara chief medical officer, replacing Andreas Muehler

Reuters
·
Apr 28

BRIEF-Immunic Appoints Biopharmaceutical Executive Michael Panzara As Chief Medical Officer

Reuters
·
Apr 28

Immunic Appoints Accomplished Biopharmaceutical Executive Michael a. Panzara, M.d., M.p.h., as Chief Medical Officer

THOMSON REUTERS
·
Apr 28

Press Release: Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer

Dow Jones
·
Apr 28

Immunic trading halted, news pending

TIPRANKS
·
Apr 25

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

Reuters
·
Apr 25

Immunic effects 1-for-10 reverse stock split April 27

Reuters
·
Apr 23

Immunic, Inc. Announces 1-for-10 Reverse Stock Split

THOMSON REUTERS
·
Apr 23

Immunic Buy Rating: Vidofludimus Calcium’s Differentiated Efficacy and Safety Profile vs. BTK Inhibitors in Relapsing MS

TIPRANKS
·
Apr 23

Okta, Immunic, FirstEnergy, ADC, GNL Trending With Analysts

TIPRANKS
·
Apr 18

Immunic's Next-Gen Oral Multiple Sclerosis Drug Poised To Capture Share, Analyst Says

Benzinga_recent_news
·
Apr 18

Stifel Nicolaus Initiates Coverage on Immunic With Buy Rating, $2.50 Price Target

MT Newswires Live
·
Apr 17

Immunic initiated with a Buy at Stifel

TIPRANKS
·
Apr 17

Immunic Cut to Hold From Buy by D. Boral Capital

Dow Jones
·
Apr 15

Immunic Sets 1-for-10 Reverse Stock Split Plan

TIPRANKS
·
Apr 15

Immunic shareholders approved reverse stock split proposal at special meeting

Reuters
·
Apr 15

Immunic CEO Vitt gets USD 670,000 retention bonus tied to CEO transition

Reuters
·
Apr 11

Immunic to present Phase 3 MS drug vidofludimus calcium at neuroimmunology summit

Reuters
·
Apr 09

BRIEF-Immunic To Offer Up To 458.2 Million Shares Of Common Stock Registered For Resale By Selling Stockholders - SEC Filing

Reuters
·
Apr 03

Immunic files to sell 458.15M shares of common stock for holders

TIPRANKS
·
Apr 03